Business Wire

Perpetual Atomics Ltd, QSA Europe, QSA Global and Reef Origin to Collaborate on Building Radioisotope Power Systems in Europe

18.2.2026 16:44:00 CET | Business Wire | Press Release

Share

Perpetual Atomics Ltd, QSA Europe (a trading name of Loma Systems s.r.o.), QSA Global, Inc., and Reef Origin signed an MOU in Prague to collaborate on the industrialized production of radioisotope power systems in Europe.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218036211/en/

Teams from Perpetual Atomics & QSA Global (USA and Czechia) at the facilities in Czechia

This MOU builds on the existing collaboration between QSA Global, Inc. and Perpetual Atomics Ltd by expanding and strengthening the capacity and capability to produce radioisotope power systems in Europe. The key partnership with QSA Europe provides access to existing facilities, capabilities, knowledge, and know-how for the storage, handling, and distribution of commercial radioisotope systems for terrestrial applications. This capability is directly transferable to radioisotope power technologies for space.

Radioisotope and nuclear power technologies are recognized as essential for a range of operational scenarios in space, including the challenge of in-space resource utilization.

Focusing initially on Radioisotope Heater Units (RHUs), this first step will address the assembly of RHUs in Europe at scale with the aim of expanding this capability based on market and customer requirements. This MOU also builds on recent announcements regarding European americium supply chain agreements signed by Perpetual Atomics.

Building on Perpetual Atomics’ 2024 launch, this development further underscores the company’s commitment to integrating technology, strategic partnerships, and innovation at the core of its operations, with a focus on delivering deployable, real-world solutions.

About QSA Europe Established in 2012 in Dobřany, Czech Republic, QSA Europe (a trading name of Loma Systems s.r.o.) is the European manufacturing and distribution headquarters of QSA Global, Inc. As a premier provider of industrial radioisotope solutions, the facility leverages its established quality program and regulatory expertise to serve as a critical infrastructure hub for the production of radioisotope power systems for the European space sector.

About Perpetual Atomics Perpetual Atomics builds on over 20 years of expertise in space nuclear power systems, space science, and space exploration. Perpetual Atomics, a spinout from the University of Leicester, is a global leader in americium-based radioisotope power technologies and their applications. Working across the full vertical — from fuel to heat sources and radioisotope power systems — Perpetual Atomics provides innovative solutions to space mission power challenges, supporting “survive the night” capability and operation in the most demanding environments.

About QSA Global, Inc. QSA Global, with decades of experience designing and producing commercial radioisotope sealed sources for industrial use in the harshest terrestrial environments, is a natural partner for this development. The company’s infrastructure, quality systems, and proven track record make it an ideal collaborator as Perpetual Atomics expands its portfolio and international footprint.

About Reef Origin: Reef Origin, founded in 2001, has a global portfolio of assets with an enterprise value of £20 billion, comprising a sustainable earth and space economy. As a developer, operator, and investor with thematic platforms across the real estate, digital and energy infrastructure, and resources and technology sectors, globally, the collaboration supports their investment ambitions.

Professor Richard Ambrosi, Chief Scientific Officer and founding director of Perpetual Atomics, said: “Radioisotope power technologies are becoming increasingly important for a range of applications in space. This collaboration provides a pathway to establishing a European radioisotope production capability. The multi-decadal expertise in space nuclear power systems within Perpetual Atomics, covering the whole vertical, as well as its partnerships and collaborations are enabling the deployment of radioisotope products and systems.”

Jake Bourn, VP/GM at QSA Global, Inc., said: “This agreement represents a strategic expansion of QSA Europe’s mission. We are committed to dedicating our resources and expertise in the Czech Republic to building a robust manufacturing capability that meets the growing demand for reliable space power. This partnership ensures that the infrastructure we establish today will support the European space economy for decades to come.”

Dr. Joe Lapinskas, Director of Innovation and Marketing at QSA Global, Inc., said: “This expanded partnership marks the next critical step in establishing the infrastructure for European radioisotope power system production. We are building upon QSA Europe’s established quality program, deeply rooted regulatory relationships, and proven distribution capabilities to create the industrial backbone needed for the reliable manufacturing and safe delivery of radioisotope-based heat and power systems.”

Piers Slater, CEO of Reef Origin said: “We are thrilled about this first investment from Reef Origin’s energy and resource division. This collaboration fits our strategy of investing in assets that share sustainable and scarcity characteristics, supporting our broader mission to deliver a sustainable earth and space economy.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20260218036211/en/

Contacts

For further information and interview requests, please contact:
info@perpetualatomics.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Codethink Opens Early Access to IEC 61508 Mapping for the Eclipse Trustable Software Framework11.3.2026 08:07:00 CET | Press Release

EMBEDDED WORLD--Codethink today opened early access to its mapping between the Eclipse Trustable Software Framework (TSF) and IEC 61508, the international standard governing the functional safety of electrical and electronic systems. The mapping establishes a transparent relationship between the engineering principles of the Trustable Software Framework and the objectives defined in IEC 61508. By making this work available as an early preview, Codethink is inviting organisations interested in applying open source approaches to functional safety to review and begin working with the mapping while the work continues to mature. IEC 61508 forms the foundation of many domain-specific safety standards, including ISO 26262 for automotive systems. The early access reflects Codethink’s long-standing commitment to open development of software engineering methods. “This preview release reflects our belief that trust in software must be engineered in the open," said Paul Sherwood, Codethink’s Chair

Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering11.3.2026 07:00:00 CET | Press Release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering (“ABO”) of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (Private Equities Department) and Auba Investment Pte. Ltd. (all together the “Selling Shareholders”) launched yesterday evening. The repurchase was made at the same price per share determined by the bookbuilding offering. As a result of yesterday evening’s ABO, the Selling Shareholders have fully divested their remaining stake in Galderma. The repurchase, which is expected to settle on March 13 is being financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to deliver on its strategic and financing priorities. The shares will be held in treasury for future use in connection with Galderma's employe

Thales Launches SkyDefender: The Integral Air and Missile Defence Dome With Artificial Intelligence11.3.2026 07:00:00 CET | Press Release

As air and missile threats are evolving faster than ever, from slow-moving drones to hypersonic missiles, attacks are becoming increasingly complex, saturating and unpredictable. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310398606/en/ SkyDefender © Thales Thales SkyDefender provides full protection against all types of air threats, from a few kilometres to several thousands of kilometres: Short-range: for protection of forces, vital assets and sensitive sites: ForceShield creates a real protection bubble against lower layer and surface threats at very short- and short-range, such as drones. Medium-range: for protection at theatre-level defence: SAMP-T NG by eurosam1 with up to 150 km engagement range, including Thales’ powerful Ground Fire radar with 350 km range and 360°/90° coverage against medium-range defence. Long-range: for protection against long-range threats with early-warning capabilities: a unique capacity

Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan11.3.2026 07:00:00 CET | Press Release

Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology disorders, today announce an exclusive license and development agreement for corticorelin (C-PTBE-01) in Japan. Under the terms of the agreement, Neupharma will receive exclusive rights to develop and commercialize corticorelin for the treatment of peritumoral brain edema (PTBE) in Japan. PTBE is a tumor-associated condition for which no approved targeted therapies currently exist. Neupharma will finance and conduct a pivotal clinical trial in Japan to support filing for approval in Japan. Curatis will receive upfront and milestone payments for the achievement of regulatory and commercial targets totaling up to CHF 83.5 million, as well as royalties on future sales in Japan of up to 20%. The agreement stipulates that corticorelin is planned to be introduced in Japan initially for children and adolescents. A meeting with

FERM FOOD Acquires Orkla’s Former Site and Scales Up: Up to 20,000 Tonnes of Fermented Ingredients Per Year11.3.2026 07:00:00 CET | Press Release

Danish ingredient producer FERM FOOD is acquiring Orkla’s former manufacturing site in Skovlund, Denmark, effective 1 April 2026. The acquisition provides new production facilities to expand the output of fermented plant-based ingredients for the food industry — driven by export demand that has emerged faster than expected. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310904877/en/ Jens Legarth (CEO), Rikke Matthiesen (CSO), and Torbjørn Tyndkjær-Thomsen (Food & Process Developer) at FERM FOOD’s new production facilities. “We have outgrown our current facilities. With the Skovlund site, we can supply many more food manufacturers in Denmark and abroad. Global interest has developed faster than we expected — and that is why we are scaling up now,” says Jens Legarth, CEO of FERM FOOD. Once fully ramped up, the new fermentation facility is expected to reach an annual capacity of up to 20,000 tonnes, depending on product mix

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye